SmithW, AndrewesCH, LaidlawPP. A virus obtained from influenza patients. Lancet1933;2:66–68.
2.
Stuart-HarrisCH, SchildGC. Influenza. The virus and the disease. Littleton MA: Publishing Sciences Group Inc, 1976.
3.
PaleseP, YoungJF. Variation of influenza A, B, and C viruses. Science1982;215:1468–1474.
4.
FoyHM, CooneyMK, AllanI, KennyGE. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA1979;241:253–258.
5.
GlezenWP, PayneAA, SnyderDN, DownsTD. Mortality and influenza. J Infect Dis1982;146:313–321.
6.
CouchRB, KaselJA, GlezenWP, . Influenza: Its control in persons and populations. J Infect Dis1986;153:431–440.
7.
AllingDW, BlackwelderWC, Stuart-HarrisCH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol1981;113:30–43.
8.
BarkerWH, MulloolyJP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol1980;112:798–813.
9.
SalkJE. Reactions to concentrated influenza virus vaccines. J Immunol1948;58:369–395.
MeyerHM, HoppsHE, ParkmanPD, EnnisFA. Review of existing vaccines for influenza. Am J Clin Path1978; 70:146–152.
12.
Recommendations of the Immunization Practices Advisory Committee (ACIP). Prevention and control of influenza. MMWR1986;35:317–331.
13.
HallCB, DouglasRG. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics1975;55:673–677.
14.
KopilaR, LintzDI, TecsonFT, ZiskinL, LouriaDB. A nosocomial outbreak of influenza A. Chest1977;71:576–579.
15.
Van VorisLP, BelsheRB, SchafferJL. Nosocomial influenza B virus infection in the elderly. Ann Intern Med1982;96:153–158.
16.
HoffmanPC, DixonRE. Control of influenza in the hospital. Ann Intern Med1977;87:725–728.
17.
WrightPF, JohnsonPR, KarzonDT. Clinical experience with live, attenuated vaccines in children. In: KendalAP, PatriarcaPA, editors. Options for the control of influenza. New York: AR Liss; 1986:43–253.
18.
DaviesWL, GrunertRR, HoffRF, . Antiviral activity of 1-adamantanamine (amantadine). Science1964;144:862–863.
19.
DouglasRG. Amantadine as an antiviral agent in influenza. N Engl J Med1982;307:617–618.
20.
HoradamVW, SharpJG, SmilakJD, . Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med1981;94:454–458.
21.
GalbraithAW, OxfordJS, SchildGC, PotterCW, WatsonGI. Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A/Hong Kong infection. Lancet1971;2:113–116.
22.
YounkinSW, BettsRF, RothFK, DouglasRG. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 (H1N1) infection after treatment with aspirin or amantadine. Antimicrobial Agents Chemother1983;23:577–582.
23.
LittleJW, HallWJ, DouglasRG, HydeRW, SpeersDM. Amantadine effect on peripheral airway abnormalities in influenza. Ann Intern Med1976;85:177–182.
24.
GlezenWP, DennyFW. Epidemiology of acute lower respiratory disease in children. N Engl J Med1973;288:498–505.
25.
GlezenWP, ParedesA, TaberLH. Influenza in children. Relationship to other respiratory agents. JAMA1980;243:1345–1349.
26.
BisnoAL, GriffinJP, Van EppsKA, NeillHB, RytelMW. Pneumonia and Hong Kong influenza: A prospective study of the 1968-1969 epidemic. Am J Med Sci1971;261:251–263.
27.
SchwarzmannSW, AdlerJL, SullivanRJ, MarineWM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med1971;127:1037–1041.
